DK Life Science Co., Ltd. (KOSDAQ:303810)
South Korea · Delayed Price · Currency is KRW 3,565.00
-35.00 (-0.97%)
At close: Feb 20, 2026
DK Life Science Market Cap
DK Life Science has a market cap or net worth of 114.02 billion as of February 20, 2026.
Market Cap
114.02B
Enterprise Value
144.35B
Revenue
131.17B
Ranking
n/a
PE Ratio
9.40
Stock Price
3,565.00
Market Cap Chart
Since February 17, 2025, DK Life Science's market cap has decreased from 200.38B to 114.02B, a decrease of -43.10%. That is a compound annual growth rate of -42.83%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 20, 2026 | 114.02B | -2.60% |
| Dec 30, 2025 | 117.06B | -41.58% |
| Feb 17, 2025 | 200.38B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 79.16T |
| Celltrion | 52.09T |
| ALTEOGEN | 20.43T |
| Sam Chun Dang Pharm. | 12.44T |
| Shinhung | 128.16B |
| Jeil Pharma Holdings | 124.80B |
| CKD Bio | 115.48B |
| IMB Dx | 114.53B |